Strategic Global Advisors, LLC Astrazeneca PLC Transaction History
Strategic Global Advisors, LLC
- $500 Million
- Q1 2025
A detailed history of Strategic Global Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Strategic Global Advisors, LLC holds 2,915 shares of AZN stock, worth $198,103. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,915
Previous 9,243
68.46%
Holding current value
$198,103
Previous $605,000
64.63%
% of portfolio
0.04%
Previous 0.11%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,418Shares Held
507MCall Options Held
8.14MPut Options Held
3.15M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.88 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.76 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.42 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.16 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.13 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $211B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...